Engineering the best transplant outcome for high-risk acute myeloid leukemia: the donor, the graft and beyond-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Engineering the best transplant outcome for high-risk acute myeloid leukemia: the donor, the graft and beyond

Published:2023-12 Issue: Volume: Page:
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Belbachir Safia,Abraham Allistair^ORCID,Sharma Akshay^ORCID,Prockop Susan,DeZern Amy E.,Bonfim Carmem,Bidgoli Alan^ORCID,Li Jinjing^ORCID,Ruggeri Annalisa,Bertaina Alice,Boelens Jaap Jan^ORCID,Purtill Duncan^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference132 articles.

1. One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non- identical family donors;Niederwieser;Haematologica,2021

2. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN;Döhner;Blood,2022

3. Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials;Heinicke;Annals of Hematology,2021

4. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet;Döhner;Blood,2010

5. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Döhner;Blood,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP